ANT Neuro
Private Company
Total funding raised: $4.7M
Overview
ANT Neuro is a long-established, privately-held developer of sophisticated neurodiagnostic and research equipment, primarily focused on electroencephalography (EEG) and neuronavigation. The company's core offering is the eego™ line of high-performance EEG amplifiers, complemented by a full ecosystem of EEG caps, software, and the FDA-cleared visor2™ TMS neuronavigation system. With a strong global distribution and support network, ANT Neuro serves a diverse market spanning academic research, clinical diagnostics, and therapeutic applications like neurofeedback and TMS. Its business model is based on selling hardware, software, and related accessories, positioning it as a revenue-generating tools provider in the growing neurotech space.
Technology Platform
High-performance EEG amplifier platform (eego™) supporting 8-256 channels, integrated with EEG caps, software, and FDA-cleared neuronavigation (visor2™) for precise TMS/FUS therapy guidance.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
ANT Neuro competes in the specialized EEG and neuronavigation market against companies like Brain Products, BioSemi, and Compumedics Neuroscan, as well as broader medical device firms like Natus and Philips. Its differentiation is based on high signal quality, a comprehensive product ecosystem, and a strong focus on community and support through its Academy and Neuromeeting.